Blood: Contamination

Department of Health written question – answered on 2nd July 2015.

Alert me about debates like this

Photo of Margaret Ritchie Margaret Ritchie Social Democratic and Labour Party, South Down

To ask the Secretary of State for Health, what progress his Department has made on licencing the Harvoni form of ledipasvir-sofosbuvir for people who have been contaminated by blood products; and if he will make a statement.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

Harvoni (ledipasvir-sofosbuvir) has been authorised by the European Commission and a Marketing Authorisation was issued on 17 November 2014 for the treatment of chronic hepatitis C in adults.

The National Institute for Health and Care Excellence is currently developing technology appraisal guidance for the National Health Service on the clinical and cost-effectiveness of Harvoni (ledipasvir-sofosbuvir) in the treatment of chronic hepatitis C and expects to publish its final guidance later this year.

Does this answer the above question?

Yes0 people think so

No2 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.